InsidersTradesSigma
之江生物: directors' dealings · France · AMF
SSE:688317FR·AMFMcap 3.9Bn€
Explore the full management transaction log of 之江生物, a listed equity based in France. Shares trade on FR FR, under the authority of AMF. Market capitalisation: €3.9bn. The latest transaction was disclosed on 5 February 2024 (Purchase). Among the most active insiders: 邵俊斌. The full history is free.
5
Insider Decl.
0
Thresholds
·
5 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
19.69 €
Income statement
Revenue124.8 M€
Gross profit80.1 M€64% margin
Net income−34.3 M€-27.5% margin
Balance sheet & cash
Market cap3.88 Bn€
Total debt299.0 M€
Free Cash Flow64.9 M€
Last declaration on 5 February 2024
Declarations5 total
5 of 5 declarations